Giovannini Annalisa Elena Jolanda, van den Borne Bart Henricus Philippus, Wall Samantha Kay, Wellnitz Olga, Bruckmaier Rupert Max, Spadavecchia Claudia
Department of Clinical Veterinary Medicine, Anesthesiology and Pain Therapy Section, Vetsuisse Faculty, University of Berne, Laenggassstrasse 124, 3012, Berne, Switzerland.
Veterinary Public Health Institute, Vetsuisse Faculty, University of Berne, Schwarzenburgstrasse 155, 3097, Liebefeld, Switzerland.
Acta Vet Scand. 2017 Jun 14;59(1):40. doi: 10.1186/s13028-017-0306-z.
Pain accompanying mastitis has gained attention recently as a relevant welfare compromising aspect of disease. Adequate pain recognition and therapy are necessary in the context of a modern and ethically acceptable dairy care. For research purposes mastitis is often induced by intramammary infusion of immunogenic bacterial cell wall components. Lipopolysaccharide (LPS) from Escherichia coli and lipoteichoic acid (LTA) from Staphylococcus aureus are commonly administered to this end. While the immune response to specific immunogenic components has been well characterized, not much is known about their role on the expression of pain indicators. The aim of this study was to trial the effects of an intramammary challenge of LTA or LPS on the degree of pain and discomfort as indicated by both physiological and behavioral variables in cows. The hypothesis was that a similar degree of pain can be identified in LTA as well as in LPS induced mastitis.
On the challenge day, compared to pre-challenge, total pain index increased for all treatment groups (LPS; LTA and control), the LPS group having significantly higher values than the control group (P = 0.01). Similarly, pain visual analogue scale (VAS) increased significantly in all cows following treatment on the challenge day. Furthermore, compared to baseline, higher VAS were found 3, 4 and 5 h after the challenge in cows of the LPS group (P < 0.001 and P = 0.001) and 7 h after the challenge in cows of the LTA group (P = 0.002). In the control group, VAS was higher 5 h after the challenge (P = 0.001). On the challenge day, udder edema was higher in the LPS than in the control group (P = 0.007). Furthermore, 4 h after the challenge, milk cortisol was significantly higher than at baseline in the LPS group (P < 0.001).
When administered at equipotent doses targeting a standard somatic cell count increase, intramammary LPS seems to be accompanied by a higher degree of pain and discomfort than LTA, as suggested by the modifications of the outcome variables total pain index, VAS, udder edema and milk cortisol.
乳腺炎伴随的疼痛作为疾病中一个关乎动物福利的相关方面,近来受到了关注。在现代且符合伦理道德的奶牛护理背景下,充分的疼痛识别与治疗是必要的。出于研究目的,乳腺炎通常通过向乳腺内注入免疫原性细菌细胞壁成分来诱发。为此,常用的是来自大肠杆菌的脂多糖(LPS)和来自金黄色葡萄球菌的脂磷壁酸(LTA)。虽然对特定免疫原性成分的免疫反应已得到充分表征,但对于它们在疼痛指标表达方面的作用却知之甚少。本研究的目的是试验乳腺内注射LTA或LPS对奶牛生理和行为变量所表明的疼痛和不适程度的影响。假设是在LTA诱导的乳腺炎和LPS诱导的乳腺炎中可识别出相似程度的疼痛。
在激发日,与激发前相比,所有治疗组(LPS组、LTA组和对照组)的总疼痛指数均升高,LPS组的值显著高于对照组(P = 0.01)。同样,在激发日治疗后,所有奶牛的疼痛视觉模拟量表(VAS)均显著升高。此外,与基线相比,LPS组奶牛在激发后3、4和5小时的VAS更高(P < 0.001和P = 0.001),LTA组奶牛在激发后7小时的VAS更高(P = 0.002)。在对照组中,激发后5小时的VAS更高(P = 0.001)。在激发日,LPS组的乳房水肿高于对照组(P = 0.007)。此外,激发后4小时,LPS组的乳皮质醇显著高于基线水平(P < 0.001)。
当以等效剂量给药以达到标准体细胞计数增加时,如总疼痛指数、VAS、乳房水肿和乳皮质醇等结果变量的变化所示,乳腺内注射LPS似乎比LTA伴随更高程度的疼痛和不适。